Cancers, 2072-6694

Journal

  1. 2021
  2. 2020
  3. Niu, F., Dzikiewicz-Krawczyk, A., Koerts, J., de Jong, D., Wijenberg, L., Fernandez Hernandez, M., Slezak-Prochazka, I., Winkle, M., Kooistra, W., van der Sluis, T., Rutgers, B., Terpstra, M. M., Kok, K., Kluiver, J., & van den Berg, A. (2020). MiR-378a-3p Is Critical for Burkitt Lymphoma Cell Growth. Cancers, 12(12), 1-18. [3546]. https://doi.org/10.3390/cancers12123546
  4. van Eck, I., den Hollander, D., Desar, I. M. E., Soomers, V. L. M. N., van de Sande, M. A. J., de Haan, J. J., Verhoef, C., Vriens, I. J. H., Bonenkamp, J. J., van der Graaf, W. T. A., van Houdt, W. J., & Husson, O. (2020). Unraveling the Heterogeneity of Sarcoma Survivors' Health-Related Quality of Life Regarding Primary Sarcoma Location: Results from the SURVSARC Study. Cancers, 12(11), 1-21. [3083]. https://doi.org/10.3390/cancers12113083
  5. Jendryczko, K., Chudzian, J., Skinder, N., Opaliński, Ł., Rzeszótko, J., Wiedlocha, A., Otlewski, J., & Szlachcic, A. (2020). FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1. Cancers, 12(10), [12102992]. https://doi.org/10.3390/cancers12102992
  6. Zheng, G., Catalano, C., Bandapalli, O. R., Paramasivam, N., Chattopadhyay, S., Schlesner, M., Sijmons, R., Hemminki, A., Dymerska, D., Lubinski, J., Hemminki, K., & Försti, A. (2020). Cancer Predisposition Genes in Cancer-Free Families. Cancers, 12(10), 1-13. https://doi.org/10.3390/cancers12102770
  7. Ettaieb, M. H. T., van Kuijk, S. M. J., de Wit-Pastoors, A., Feelders, R. A., Corssmit, E. P. M., Eekhoff, E. M. W., van der Valk, P., Timmers, H. J. L. M., Kerstens, M. N., Klümpen, H-J., Leeuwaarde, V. R. S., Havekes, B., & Haak, H. R. (2020). Development and Internal Validation of a Multivariable Prediction Model for Adrenocortical-Carcinoma-Specific Mortality. Cancers, 12(9), 1-16. [2720]. https://doi.org/10.3390/cancers12092720
  8. Soomers, V. L. M. N., Desar, I. M. E., van de Poll-Franse, L. V., van de Sande, M. A. J., de Haan, J. J., Verhoef, C., Vriens, I. J. H., van Houdt, W. J., Bonenkamp, J. J., van der Graaf, W. T. A., & Husson, O. (2020). The Perceived Impact of Length of the Diagnostic Pathway Is Associated with Health-Related Quality of Life of Sarcoma Survivors: Results from the Dutch Nationwide SURVSARC Study. Cancers, 12(8), 1-13. [2088]. https://doi.org/10.3390/cancers12082088
  9. van der Kooij, M. K., Wetzels, M. J. A. L., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Blank, C. U., Boers-Sonderen, M. J., Dierselhuis, M. P., de Groot, J. W. B., Hospers, G. A. P., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., Ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., Haanen, J. B. A. G., van den Eertwegh, A. J. M., Bastiaannet, E., & Kapiteijn, E. (2020). Age Does Matter in Adolescents and Young Adults versus Older Adults with Advanced Melanoma; A National Cohort Study Comparing Tumor Characteristics, Treatment Pattern, Toxicity and Response. Cancers, 12(8), 1-15. [2072]. https://doi.org/10.3390/cancers12082072
  10. den Toom, I. J., Boeve, K., Lobeek, D., Bloemena, E., Donswijk, M. L., de Keizer, B., Klop, W. M. C., Leemans, C. R., Willems, S. M., Takes, R. P., Witjes, M. J. H., & de Bree, R. (2020). Elective Neck Dissection or Sentinel Lymph Node Biopsy in Early Stage Oral Cavity Cancer Patients: The Dutch Experience. Cancers, 12(7), [1783]. https://doi.org/10.3390/cancers12071783
  11. Nieuwenhuizen, S., Puijk, R. S., van den Bemd, B., Aldrighetti, L., Arntz, M., van den Boezem, P. B., Bruynzeel, A. M. E., Burgmans, M. C., de Cobelli, F., Coolsen, M. M. E., Dejong, C. H. C., Derks, S., Diederik, A., van Duijvendijk, P., Eker, H. H., Engelsman, A. F., Erdmann, J., Futterer, J. J., Geboers, B., ... Meijerink, M. R. (2020). Resectability and Ablatability Criteria for the Treatment of Liver Only Colorectal Metastases: Multidisciplinary Consensus Document from the COLLISION Trial Group. Cancers, 12(7), 1-17. [1779]. https://doi.org/10.3390/cancers12071779
  12. Schatz, S., Falk, M., Jóri, B., Ramdani, H. O., Schmidt, S., Willing, E-M., Menon, R., Groen, H. J. M., Diehl, L., Kröger, M., Wesseler, C., Griesinger, F., Hoffknecht, P., Tiemann, M., & Heukamp, L. C. (2020). Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer. Cancers, 12(6), 1-14. [1685]. https://doi.org/10.3390/cancers12061685
  13. Veronesi, G., Baldwin, D. R., Henschke, C. I., Ghislandi, S., Iavicoli, S., Oudkerk, M., De Koning, H. J., Shemesh, J., Field, J. K., Zulueta, J. J., Horgan, D., Fiestas Navarrete, L., Valentino Infante, M., Novellis, P., Murray, R. L., Peled, N., Rampinelli, C., Rocco, G., Rzyman, W., ... Pelosi, G. (2020). Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe. Cancers, 12(6), 1-24. [1672]. https://doi.org/10.3390/cancers12061672
  14. Weber, S., Spiegl, B., Perakis, S. O., Ulz, C. M., Abuja, P. M., Kashofer, K., Leest, P. V. D., Azpurua, M. A., Tamminga, M., Brudzewsky, D., Rothwell, D. G., Mohan, S., Sartori, A., Lampignano, R., Konigshofer, Y., Sprenger-Haussels, M., Wikman, H., Bergheim, I. R., Kloten, V., ... Heitzer, E. (2020). Technical Evaluation of Commercial Mutation Analysis Platforms and Reference Materials for Liquid Biopsy Profiling. Cancers, 12(6), 1-16. [1588]. https://doi.org/10.3390/cancers12061588
  15. Niu, F., Kazimierska, M., Nolte, I. M., Terpstra, M. M., de Jong, D., Koerts, J., van der Sluis, T., Rutgers, B., O'Connell, R. M., Kok, K., van den Berg, A., Dzikiewicz-Krawczyk, A., & Kluiver, J. (2020). The miR-26b-5p/KPNA2 Axis Is an Important Regulator of Burkitt Lymphoma Cell Growth. Cancers, 12(6), 1-20. [1464]. https://doi.org/10.3390/cancers12061464
  16. Dias, F., Teixeira, A. L., Nogueira, I., Morais, M., Maia, J., Bodo, C., Ferreira, M., Silva, A., Vilhena, M., Lobo, J., Sequeira, J. P., Maurício, J., Oliveira, J., Kok, K., Costa-Silva, B., & Medeiros, R. (2020). Extracellular Vesicles Enriched in hsa-miR-301a-3p and hsa-miR-1293 Dynamics in Clear Cell Renal Cell Carcinoma Patients: Potential Biomarkers of Metastatic Disease. Cancers, 12(6), [1450]. https://doi.org/10.3390/cancers12061450
  17. Roze, J., Monroe, G., Kutzera, J., Groeneweg, J., Stelloo, E., Paijens, S., Nijman, H., Meurs, H. V., Lonkhuijzen, L. V., Piek, J., Lok, C., Jonges, G., Witteveen, P., Verheijen, R., Haaften, G. V., & Zweemer, R. (2020). Whole Genome Analysis of Ovarian Granulosa Cell Tumors Reveals Tumor Heterogeneity and a High-Grade TP53-Specific Subgroup. Cancers, 12(5), [1308]. https://doi.org/10.3390/cancers12051308
  18. Primavesi, F., Andreasi, V., Hoogwater, F. J. H., Partelli, S., Wiese, D., Heidsma, C., Cardini, B., Klieser, E., Marsoner, K., Froeschl, U., Thalhammer, S., Fischer, I., Goebel, G., Hauer, A., Kiesslich, T., Ellmerer, P., Klug, R., Neureiter, D., Wundsam, H., ... Staettner, S. (2020). A Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study. Cancers, 12(5), [1235]. https://doi.org/10.3390/cancers12051235
  19. Blankenstein, S. A., Aarts, M. J. B., van den Berkmortel, F. W. P. J., Boers-Sonderen, M. J., van den Eertwegh, A. J. M., Franken, M. G., de Groot, J. W. B., Haanen, J. B. A. G., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., & van Akkooi, A. C. J. (2020). Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy. Cancers, 12(5), [1176]. https://doi.org/10.3390/cancers12051176
  20. Leeneman, B., Uyl-de Groot, C. A., Aarts, M. J. B., van Akkooi, A. C. J., van den Berkmortel, F. W. P. J., van den Eertwegh, A. J. M., de Groot, J. W. B., Herbschleb, K. H., van der Hoeven, J. J. M., Hospers, G. A. P., Kapiteijn, E., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ten Tije, A. J., van der Veldt, A. A. M., Vreugdenhil, G., Wouters, M. W. J. M., Haanen, J. B. A. G., & Franken, M. G. (2020). Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs. Cancers, 12(4), [1003]. https://doi.org/10.3390/cancers12041003
  21. Lohman, E. D. S., de Bitter, T., Verhoeven, R., van der Geest, L., Hagendoorn, J., Mohammad, N. H., Daams, F., Klumpen, H-J., van Gulik, T., Erdmann, J., de Boer, M., Hoogwater, F., Koerkamp, B. G., Braat, A., Verheij, J., Nagtegaal, I., van Laarhoven, C., van den Boezem, P., van der Post, R., & de Reuver, P. (2020). Trends in Treatment and Survival of Gallbladder Cancer in the Netherlands; Identifying Gaps and Opportunities from a Nation-Wide Cohort. Cancers, 12(4), [918]. https://doi.org/10.3390/cancers12040918
  22. Agahozo, M. C., Timmermans, M. A. M., Sleddens, H. F. B. M., Foekens, R., Trapman-Jansen, A. M. A. C., Schröder, C. P., van Leeuwen-Stok, E., Martens, J. W. M., N M Dinjens, W., & van Deurzen, C. H. M. (2020). Loss of Y-Chromosome during Male Breast Carcinogenesis. Cancers, 12(3), [631]. https://doi.org/10.3390/cancers12030631
  23. IJzerman, N. S., Drabbe, C., den Hollander, D., Mohammadi, M., van Boven, H., Desar, I. M. E., Gelderblom, H., Grünhagen, D. J., Reyners, A. K. L., van Noesel, M. M., Mathijssen, R. H. J., Steeghs, N., & van der Graaf, W. T. A. (2020). Gastrointestinal Stromal Tumours (GIST) in Young Adult (18-40 Years) Patients: A Report from the Dutch GIST Registry. Cancers, 12(3), [730]. https://doi.org/10.3390/cancers12030730
  24. 2019
  25. Betancourt, L. H., Szasz, A. M., Kuras, M., Rodriguez Murillo, J., Sugihara, Y., Pla, I., Horvath, Z., Pawłowski, K., Rezeli, M., Miharada, K., Gil, J., Eriksson, J., Appelqvist, R., Miliotis, T., Baldetorp, B., Ingvar, C., Olsson, H., Lundgren, L., Horvatovich, P., ... Marko-Varga, G. (2019). The Hidden Story of Heterogeneous B-raf V600E Mutation Quantitative Protein Expression in Metastatic Melanoma-Association with Clinical Outcome and Tumor Phenotypes. Cancers, 11(12). https://doi.org/10.3390/cancers11121981
  26. Schouwenburg, M. G., Suijkerbuijk, K. P. M., Koornstra, R. H. T., Jochems, A., van Zeijl, M. C. T., van den Eertwegh, A. J. M., Haanen, J. B. A. G., Aarts, M. J., Akkooi, A. C. J. V., Berkmortel, F. W. P. J. V. D., Groot, J. W. B. D., Hospers, G. A. P., Kapiteijn, E., Kruit, W. H., Piersma, D., van Rijn, R. S., Ten Tije, A. J., Vreugdenhil, G., Hoeven, J. J. M. V. D., & Wouters, M. W. J. M. (2019). Switching to Immune Checkpoint Inhibitors upon Response to Targeted Therapy; The Road to Long-Term Survival in Advanced Melanoma Patients with Highly Elevated Serum LDH? Cancers, 11(12), [1940]. https://doi.org/10.3390/cancers11121940
  27. Chau, C., van Doorn, R., van Poppelen, N. M., van der Stoep, N., Mensenkamp, A. R., Sijmons, R. H., van Paassen, B. W., van den Ouweland, A. M. W., Naus, N. C., van der Hout, A. H., Potjer, T. P., Bleeker, F. E., Wevers, M. R., van Hest, L. P., Jongmans, M. C. J., Marinkovic, M., Bleeker, J. C., Jager, M. J., Luyten, G. P. M., & Nielsen, M. (2019). Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines. Cancers, 11(8), [1114]. https://doi.org/10.3390/cancers11081114
  28. Jochems, A., van der Kooij, M. K., Fiocco, M., Schouwenburg, M. G., Aarts, M. J., van Akkooi, A. C., van den Berkmortel, F. W. P. J., Blank, C. U., van den Eertwegh, A. J. M., Franken, M. G., de Groot, J. B., Haanen, J. B. A. G., Hospers, G. A. P., Koornstra, R. H., Kruit, W. H. J., Louwman, M., Piersma, D., van Rijn, R. S., Suijkerbuijk, K. P. M., ... Kapiteijn, E. (2019). Metastatic Uveal Melanoma: Treatment Strategies and Survival-Results from the Dutch Melanoma Treatment Registry. Cancers, 11(7), [1007]. https://doi.org/10.3390/cancers11071007
  29. Rijken, J. A., Dekkers, O. M., Niemeijer, N. D., Leemans, C. R., Eijkelenkamp, K., van der Horst-Schrivers, A. N. A., Kerstens, M. N., van Berkel, A., Timmers, H. J. L. M., Kunst, H. P. M., Bisschop, P. H. L. T., Dreijerink, K. M. A., van Dooren, M. F., Hes, F. J., Jansen, J. C., Corssmit, E. P. M., & Hensen, E. F. (2019). Increased Mortality in SDHB but Not in SDHD Pathogenic Variant Carriers. Cancers, 11(1), [103]. https://doi.org/10.3390/cancers11010103
  30. 2018
  31. 2015
  32. Dohmen, A. J. C., Swartz, J. E., Van Den Brekel, M. W. M., Willems, S. M., Spijker, R., Neefjes, J., & Zuur, C. L. (2015). Feasibility of Primary Tumor Culture Models and Preclinical Prediction Assays for Head and Neck Cancer: A Narrative Review. Cancers, 7(3), 1716-1742. https://doi.org/10.3390/cancers7030858
Previous 1 2 Next

ID: 13465724